TY - JOUR
T1 - Cellular mechanism of the QT prolongation induced by sulpiride
AU - Lee, Hyang Ae
AU - Kim, Ki Suk
AU - Park, Sang Joon
AU - Kim, Eun Joo
PY - 2009
Y1 - 2009
N2 - In this study, the authors investigated the electrophysiological effect of sulpiride on cardiac repolarization using conventional microelectrode recording techniques in isolated canine Purkinje fibers and a wholecell patch clamp technique in transiently transfected cells with the hERG, KCNQ1/KCNE1, KCNJ2, and SCN5A cDNA and in rat cardiac myocytes for ICa. In studies of action potential duration, 10 μM, 100 μM, 300 μM, and 1mMsulpiride prolonged action potential duration in a concentration-dependent manner. In studies of cardiac ion channels, sulpiride did not significantly affect I Na, ICa, IKs, IK1, except for I Kr. Sulpiride dose-dependently decreased the hERG tail current. It is considered that the prolonged action potential duration by sulpiride was mainly the result of inhibition of the hERG channel. The data suggest that the clinical use of sulpiride is reasonable within therapeutic plasma concentrations, but all patients taking this drug should be cautiously monitored for clinical signs of long-QT syndrome and severe arrhythmia.
AB - In this study, the authors investigated the electrophysiological effect of sulpiride on cardiac repolarization using conventional microelectrode recording techniques in isolated canine Purkinje fibers and a wholecell patch clamp technique in transiently transfected cells with the hERG, KCNQ1/KCNE1, KCNJ2, and SCN5A cDNA and in rat cardiac myocytes for ICa. In studies of action potential duration, 10 μM, 100 μM, 300 μM, and 1mMsulpiride prolonged action potential duration in a concentration-dependent manner. In studies of cardiac ion channels, sulpiride did not significantly affect I Na, ICa, IKs, IK1, except for I Kr. Sulpiride dose-dependently decreased the hERG tail current. It is considered that the prolonged action potential duration by sulpiride was mainly the result of inhibition of the hERG channel. The data suggest that the clinical use of sulpiride is reasonable within therapeutic plasma concentrations, but all patients taking this drug should be cautiously monitored for clinical signs of long-QT syndrome and severe arrhythmia.
KW - Action potential
KW - HERG K+ channel
KW - QT interval prolongation
KW - Sulpiride
UR - http://www.scopus.com/inward/record.url?scp=68849117783&partnerID=8YFLogxK
U2 - 10.1177/1091581809337261
DO - 10.1177/1091581809337261
M3 - Article
C2 - 19546258
AN - SCOPUS:68849117783
SN - 1091-5818
VL - 28
SP - 207
EP - 212
JO - International Journal of Toxicology
JF - International Journal of Toxicology
IS - 3
ER -